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This article examines the conflicts which arise when patients with chronic disease engage in decision 
making with health professionals about their medication. These are conflicts in the sense of discrep-
ancies or incompatibilities between perceptions or opinions of different people engaged in a common 
endeavour. The paper is based on three qualitative research studies and presents one case from each 
study to illustrate analytical findings. Data collected in the original studies consisted of observations 
of clinical encounters and semi-structured interviews; in total 45 interviews with patients and 23 
with health professionals. The analysis shows different conflicts, which arise during the process of 
making decisions about medication. These conflicts arise when: 1) Patients deliberately hold back in-
formation about their medication for fear of challenging clinicians’ authority; 2) The decision making 
process takes place in an environment, which does not support patient involvement; and 3) Patients 
refer to pharmacological knowledge, but are considered ill-equipped to understand and apply this 
knowledge by health professionals. The article shows that these conflicts typically revolve around the 
legitimate access to and use of pharmacological knowledge. These results have important implica-
tions for the current discussions of shared decision making. In shared decision making, knowledge 
about medication is typically regarded as the domain of the doctor. We argue that there is a need for 
a widening of the concept of partnership, which is central to shared decision making, to encompass 
breadth of patient knowledge about his/her situation, disease and treatment. Patients with chronic 
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diseases need to be actively invited to disclose the extensive clinical knowledge they acquire over 
time, thereby creating a legitimate space for this knowledge in clinical consultations, and avoiding 
that conflicts over knowledge domains lead to unnecessary suffering and wasted resources.  
Resume
Denne artikel undersøger de konflikter, som opstår i samarbejdet mellem kronisk syge patienter og 
deres læger, når der skal træffes beslutninger om deres medicinske behandling. Med konflikter menes 
uoverensstemmelser mellem to forskellige, oftest uforenelige opfattelser eller meninger hos personer 
der arbejder mod et fælles mål. Artiklen baserer sig på data fra tre kvalitative empiriske studier af 
patientinddragelse, herunder observationer af kliniske møder og semistrukturerede interviews; i alt 
45 med patienter og 23 med sundhedsprofessionelle. Tre cases fra studierne præsenteres og dis-
kuteres i denne artikel. Analysen afdækkede forskellige konflikter, som opstår i beslutningstagningen 
omkring medicinsk behandling når 1) patienter tilbageholder information for ikke at udfordre lægens 
autoritet, 2) beslutningstagningen foregår i et miljø, som ikke understøtter patientinddragelse, og 
3) patienter refererer til biomedicinsk viden, men vurderes ude af stand til reelt at kunne forstå og 
anvende denne type viden. Artiklen viser, at disse konflikter typisk handler om legitim adgang til 
og brug af viden om medicinsk behandling. Disse resultater er særligt relevante for den aktuelle dis-
kussion om fælles beslutningstagning. I fælles beslutningstagning ser vi en tendens til at fastholde 
den medicinske viden som lægens domæne. På den anden side kan patienters uvilje mod at bringe 
viden om behandling på banen af frygt for at udfordre lægens autoritet medføre unødig lidelse og res-
sourcespild. Således synes konceptet fælles beslutningstagning at være delvis inkompatibelt med en 
række af de forventninger til samspillet, som patienter og sundhedsprofessionelle udspiller i daglig 
klinisk praksis. Vi argumenterer for, at der er behov for en udvidelse af begrebet partnerskab, som 
er centralt i fælles beslutningstagning, til at give plads til patientens fulde viden om sin situation, 
sygdom og behandling. Kronisk syge patienter skal inviteres eksplicit til at dele den kliniske viden, de 
har opbygget over tid for herved at skabe et legitimt rum for denne viden i konsultationer, og undgå 
at konflikter over vidensdomæner fører til unødvendig lidelse og ressourcespild. 
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Chronic Illness Management, Qualitative.
69Who knows best? Negotiations of knowledge in clinical decision making
Introduction
During the last two decades the concept of patient participation has become in-
creasingly important in Danish health care. Patient participation implies that pa-
tients are both central objects of health care services, and also agents with particu-
lar knowledge and resources, which should be taken into account when decisions 
about their care are made. Thus, patients are no longer perceived as passive reci-
pients of care, but are expected to engage actively in the management of their di-
sease1. Being active partners in health care require that patients are more involved 
in and responsible for the various processes of their care, including monitoring 
symptoms, seeking appropriate and timely medical assistance, engaging in dia-
logue with health professionals, stating their care preferences, and making infor-
med choices (Coulter & Ellins 2006). Indeed, good clinical practice is increasingly 
envisioned as a process, in which clinical facts about the disease and its treatment 
are attuned to the psycho-social background, treatment preferences and illness 
perceptions of the individual patient. This view is expressed perhaps most strong-
ly in the concept of shared decision making (Coulter & Ellins 2006; Jacobsen, Pe-
dersen, & Albeck 2008; Sheridan, Harris, & Woolf 2004). 
In a report on shared decision making targeting clinicians, Coulter and Collins 
defines the core of SDM as ‘the recognition that clinicians and patients bring different 
but equally important forms of expertise to the decision-making process’ (Coulter & Col-
lins 2011:2). They explain that the clinician’s expertise is based on knowledge of 
the diagnosis, likely prognosis, treatment and support options, and the range of 
possible outcomes based on population data. In contrast, patients’ expertise con-
sists of their knowledge of how their disease and treatment impact on their daily 
life, their personal attitude to risk and their values and preferences (Coulter & Col-
lins 2011). According to Coulter and Collins, shared decision-making implies that 
both types of expertise are taken into account, and that decisions about treatment 
and care are reached through agreement and informed by research evidence.
The increasing focus on patient participation, and shared decision making in 
particular, marks a shift in the conceptualisation of the dialogue with the patient 
in medicine. Since the late 80’s, the ideal communication between doctor and pa-
tient has been conceptualised as one of dialogue and involvement, as opposed to 
one of merely information and consent (Zinck Pedersen 2008). However, the ideal 
of dialogue and sharing of equally important forms of knowledge may mask what 
Grimen (2009) calls ‘the nexus of power, trust and risk’; i.e. that patients depend 
on doctors’ professional expertise concerning for instance the risks and benefits 
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of available treatment options and their position as gatekeepers controlling access 
to treatment, and the inferiority that follows from this dependence (Grimen 2009). 
Much in line with this critique, qualitative studies have documented a number 
of patient-related barriers to shared decision making. Among these are patients’ 
expectations to the clinical encounter; for instance some patients believe that ‘nor-
mal’ patients are mostly passive and receiving, and that clinical decisions should 
be based only on the expert knowledge of the clinician; others believe the way 
to get high-quality treatment is to get the doctor on their side by being ‘good pa-
tients’, who do not take up too much of the doctors’ time or challenge their autho-
rity (Joseph-Williams et al. 2014).
Patients with chronic disease often gain detailed insights about their disease 
and treatment. These insights span the experience of living with and managing 
chronic disease, the experience of disease progression and their body’s response 
to medication. In the process they often learn how to interpret medical informa-
tion relevant to their condition. Thus, the knowledge they glean from their si-
tuation is subjective, but they often also gain significant insight into biomedical 
knowledge about their disease and medication, which may be highly relevant in 
the clinical encounter. 
 This article describes the conflicts which sometimes occur when patients with 
chronic disease attempt to participate in decision making about pharmacological 
treatment, i.e. the domain at the heart of clinicians’ expertise. Thus it contributes 
to current discussions on shared decision making and the barriers for its imple-
mentation (Elwyn et al. 2013). It argues that there is a need for creating a legitimate 
space for patients’ knowledge about their medication in clinical consultations in 
order to avoid conflicts over knowledge domains, which can otherwise become 
barriers to the realisation of patient involvement in general and shared decision 
making in particular. 
Methods
The empirical background for this article is three qualitative studies about pa-
tient-centred health care in Danish hospitals: A study on shared decision-making 
in heart rehabilitation and arthritis care (Jacobsen et al. 2008); a study on the im-
plementation of patient participation in everyday clinical practice among patients 
and their relatives in a neurology department (Jacobsen & Petersen 2009); and a 
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study on the experience of continuity of care among patients with diabetes, cancer 
and heart disease (Martin 2010). 
Data from the three studies comprised observations during consultations, 
ward rounds, waiting time etc., as well as interviews and/or focus groups with 
patients and health professionals about their experiences with patient participa-
tion. A total of 45 patients and 23 health care professionals were interviewed in 
the three studies. In addition, 35 health professionals participated in focus groups 
in the study by Martin (2010). For the purpose of this article, we present three rich 
individual cases, illuminating central themes in the data. Each case illustrates an 
encounter between a patient and health professionals involved in their treatment. 
Although the diseases and situations of the patients varied, the cases represent 
different ways in which patients employ knowledge about their disease and/or 
medication in the clinical encounter. 
Cases
Case 1: When patient knowledge is withheld
Peter is in his 60s and has suffered from Parkinson’s disease for more than 10 ye-
ars. He recently had a heart attack and was subsequently diagnosed with ischemic 
heart disease. He takes medication to control the symptoms of Parkinson (mainly 
body stiffness and pains in muscles and joints), and to prevent another heart at-
tack (an anti-coagulant called Warafin). Peter is admitted for surgery to have an in-
testinal medicine infusion pump which can dose his Parkinson medication more 
precisely. He arrives at the ward in the morning and sees the surgeon for his ad-
mission consultation. After reading his journal and asking Peter, the surgeon rea-
lises that Peter is still taking Warafin. Anti-coagulants increase the risk of serious 
bleeding and is contraindicated before an operation. The operation is therefore 
postponed until the effect of the drug has worn off. Peter is kept on the ward, as 
the health professionals assume that he will be ready for operation the following 
day. However, it proves difficult to estimate exactly when the effect of the medica-
tion has worn off, and the operation is postponed three times. Each time Peter has 
to fast and is told not to take his Parkinson medication. Consequently, the plan-
ned operation causes Peter’s Parkinson symptoms to flare up, with the result that 
he is in great pain for some time. The staff and Peter have different opinions as to 
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who is to blame for this situation: A nurse talking to her colleagues blames Peter 
for ‘being so forgetful’, and not telling the doctor about his medication well in ad-
vance of the planned operation. When the nurse is measuring his blood pressure, 
Peter blames the doctor for having forgotten about the Warafin. But as the nurse 
leaves, Peter says to himself and the researcher besides him: “I knew it. I did. But I 
didn’t want to interfere in their affairs. I didn’t want to play the doctor.” 
Peter’s last comment tells us that there is more at stake than simple lapse of 
memory. Peter was aware that Warafin should not be taken before an operation. In 
the interview later on he blames himself for not having asked the doctor about the 
Warafin before he was admitted for the operation.
Peter: “I should not have taken Warafin, but I didn’t want to ask” (continues in a 
feigned childish voice): ‘should I then continue with Warafin?’” 
Interviewer: “So you had thought about it?
Peter: “Yes, of course, you can’t even go to the dentist when taking Warafin.”
Peter points to an important issue. He suggests that it may be considered inap-
propriate for patients to bring forth their knowledge if it interferes with the doc-
tor’s professional knowledge. 
Peter mimics a child’s voice as he poses the question he never asked during 
the consultation. His imitation defines the child’s position as one of ignorance 
and submission. Although Peter has years of experience with his disease and his 
medication, he does not want to ‘play the doctor’ and claim authority, but refrains 
from voicing his concern. By not mentioning Warafin, Peter acknowledges the 
exclusive right of the doctor to possess and act upon biomedical knowledge, and 
assumes that his participation would be an undue interference with the doctor’s 
professional domain. 
Strauss et al. have claimed that health professionals continuously judge the ac-
tions of their patients (Strauss, Fagerhaugh, Suczek, & Wiener 1997). They may 
see patients’ ‘work’2 as good or bad, rational or irrational, sensible or foolish etc. 
As Peter’s case illustrates, patients are aware of this judgement of their actions, 
and they assume that the health care professionals perceive them as ‘good’ or 
‘bad’ patients, depending on how they behave. Therefore, many patients ende-
avour to communicate in a way they think will minimize conflict and maintain a 
good relationship with the health professionals. In line with Grimen’s point that 
the power of doctors is related to access to treatment, many of the patients who 
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participated in the three research studies believed that they would obtain better 
treatment if the health professionals viewed them in a positive light. Behaving as 
a good patient, i.e. as they thought the health professionals expected them to act, 
therefore became an important strategy.
Peter’s case illustrates that the separation of clinicians’ and patients’ areas of 
expertise are, at least in part, instigated and reproduced by patients. This can be 
seen as an example of collusion - a tacit, sometimes not quite conscious, agreement 
between different actors to behave and communicate in ways that maintain the 
social order and avoid any behaviour or statements that would break it. In the case 
above, Peter makes sure that he does not challenge the doctor’s position as biome-
dical expert, and acts in a way he assumes is considered appropriate in a hospital: 
the cooperative patient who commits himself fully to hospital care. In this way, 
potential conflict is avoided and social order is maintained. Unfortunately, this 
order comes at a cost. Peter is frustrated with the way preparations for his surgery 
took place, which he sees as partly his own fault. Indeed, his case represents the 
unfortunate consequences of this submissive approach: because of his unwilling-
ness ‘to interfere’ he had to endure a week of pains and disappointment. 
Case 2: When patient knowledge is disregarded
Jane, a woman in her 40s, has had diabetes (type I) for 25 years. She takes her 
disease very seriously and carefully manages her blood sugar levels. At the time 
of the interview she had been admitted to hospital for four days to undergo recon-
structive surgery of a painful scar in the groin. During the interview, it becomes 
clear that although the clinical staff was nice and efficient, she found that their 
management of her insulin injections during her admittance was below standard. 
It was not the first time she experienced inadequate diabetic care from hospital 
staff outside the endocrinology department:
“Every time I’ve been admitted my blood sugar goes out of control. I think there is a rule 
that you cannot take your own medicine when you’re in the hospital. The staff is supposed 
to give it to you, but a surgical department is a bit like a slaughterhouse – they know how 
to operate, but they don’t know much about diabetes. So this is a problem when you have a 
chronic disease and have your check-ups in a different department where you are seen regu-
larly and they know you very well, because the departments do not cooperate. The left hand 
doesn’t know what the right hand does. So why not ask the patient? I have had diabetes for 
25 years. I could have told them what to do. But what happened was that the night before the 
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operation the night nurses forgot to check my blood sugar level and at five in the morning I 
had a hypo3. Then they gave me something sweet to drink and my blood sugar became far too 
high which is really bad when you’re going in for surgery. So during the operation they had 
to give me a lot of insulin and I felt very bad afterwards. Those four days were really tur-
bulent. If they had asked me – and I tried to tell them many times – then I needn’t have had 
that bad experience. To be honest, I also relaxed and trusted them because they seemed to be 
in control. I was nervous about the operation and was happy that they could take over a bit. 
I became very frustrated when I found out that they didn’t know how to do it. Afterwards I 
pointed out that they should consider doing things differently next time. Surely, I’m not the 
only patient with diabetes in their department. It’s not like I was annoyed or anything, and 
it was meant as a constructive comment to help other patients in the same situation, but the 
nurses just looked at me like I had no right to say that.” (edited account)
Administering insulin is a daily task for type 1 diabetics. People who live with 
diabetes for many years acquire extensive factual and experiential knowledge 
about their condition, its treatment, and how their body responds to it. Jane, who 
has had diabetes for 25 years, is an expert on her condition, and has been encou-
raged to think of herself that way at the biannual check-ups with her endocrino-
logist. Her willingness to take responsibility is something she emphasizes in the 
interview. 
However, her knowledge is not recognised by the health professionals in the 
surgery department. Instead, they take over the glycaemic control of diabetic pa-
tients and follow a generic schedule for insulin injections. This is standard pro-
cedure when patients with diabetes are admitted to the department. In the inter-
view, Jane recounts how she has initial doubts about the quality of this treatment 
approach, but that she also acknowledges the medical authority of the doctors and 
nurses she meets and therefore surrenders control of her diabetes to them.  
Jane’s case illustrates that the ideal of the active, responsible patient may not be 
compatible with the reality of decision making in all medical areas and situations. 
The active patient role advocated in the principle of patient participation applies 
easily to an outpatient department where treatment and care is centred around 
patients’ self-management of their condition. But the institutional framework of 
the surgery department contributes to the passivity of diabetic patients by encou-
raging them to give up responsibility for the medication management. 
 Jane is keen to present herself as a ‘strong patient’, who is not afraid to voice her 
needs when talking to health care professionals and who knows how to obtain the 
services she considers necessary for her treatment. As such, she is indeed a good 
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example of the active patient. Unlike Peter, she expresses her opinion about her 
treatment and care, and is not afraid to point out failures or suggest procedural 
changes to both nurses and doctors. Yet at the same time, she emphasizes that 
her aim is not to complain, but simply to get help in her pursuit of care, and that 
she has always been very friendly and tried not to annoy the doctors. By acting 
this way, she pursues two strategies simultaneously: 1) She takes responsibility, 
asserts her needs and presents her perspective, while also 2) acknowledging an 
institutional hierarchy in which the patient is dependent on the health professio-
nals and thereby constitutes the lowest level. These two strategies allow Jane to 
simultaneously maintain and challenge the social order that defines the doctor as 
the knowledgeable authority and the patient as passive and ‘unknowing’. 
Case 3: When patient knowledge leads to conflict
The last case is from an arthritis outpatient clinic. Arthritis cannot be cured and 
so treatment is focused on controlling symptoms, i.e. reducing pain and minimi-
zing the deterioration of bones and joints. When symptoms and objective disease 
markers change and warrants adjustments of medication, patient knowledge and 
professional knowledge needs to be exchanged. Blood tests, scans and mobility 
tests are employed to obtain an overview of symptoms and make decisions about 
medication. But patients’ subjective evaluations of pain and the effect of the tre-
atment contribute crucial information to the process of medical decision-making. 
However, if the boundaries between knowledge domains become blurred this ex-
change may become conflictual. This was the case in the consultation with Bet-
tina who is a middle-aged woman who has been treated for arthritis in the clinic 
for a couple of years. Prior to the consultation, the researcher observes the doctor 
preparing for the consultation. The doctor reads the patient file and notes that 
Bettina does not receive the clinic’s first-choice treatment. The doctor consults her 
colleague who encourages her to change the patient’s treatment. During the con-
sultation, the doctor tries to persuade Bettina to change medication:
Doctor: “I can see you take Salazopyrin. Was it your own choice?”
Betina: “No. I had a lot of problems with my arthritis, and that is why I got it.”
Doctor: “The results of your blood test show signs of activity. It shows 36.”
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Bettina: “The last time I was here, the doctor told me that the activity goes up with 
age. What was my CRP? Can I have a copy of the blood test results? I am a labora-
tory technician so I can understand them.”
Doctors: “Yes, you may. The activity rises as one grows older, that is correct. Howe-
ver, we must try to keep it low; that is what’s important. I have talked to my collea-
gue about it and we agree that it would be a good idea for you to change treatment 
to Methotrexate.”
Bettina: “But I am happy with the treatment I get now.”
Doctor: “We prefer Methotrexate because it has been proven to increase survival. 
That is why it is our first-choice treatment.” 
Bettina: “The other doctor told me to take Salazopyrin for a couple of years and by 
then we would see if there was any activity.”
Doctor: “I want you to know why Methotrexate is our first choice, but if you do not 
want it then…”
Bettina: “No I don’t!“
Doctor: “You don’t want to change medicine, but you also take lower doses now 
than you did at the beginning. I am not happy with that.”
Bettina: “I take two pills a day. I don’t want more unless there are changes in the 
blood test results.”
Doctor: “When I look at your results, I can see you’re undertreated. You think in 
terms of biochemistry because you are a lab technician, but not everything can be 
registered biochemically. When you get an ultrasound scan, the nurse will also 
count the number of sore joints. That is what I am looking at. I don’t look at the 
blood tests alone.”
Bettina: “Ok, so how many Salazopyrin should I take? Am I to continue with two?
Doctor: “If you want to.”
Bettina: “Ok, then let’s say that I continue with two until the ultrasound scan and 
then we can reconsider?” 
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Doctor: “Yes.”
It is clear from this quote that Bettina has a strong preference for the medicine 
she takes, and she argues her case by referring to clinical factors such as her blood 
test results rather than her personal experience of pain or side effects. The doctor 
deflects Bettina’s  knowledge of blood tests by referring to the importance of other 
clinical information – ultrasound scans and soreness of joints - which only the 
doctor can interpret. Bettina demands that the decision is made on the basis of test 
results rather than the doctor’s assessment. The atmosphere during the consulta-
tion grows tense. Not only the dialogue, but also gestures, facial expression and 
tone of voice indicate that there is a conflict over the choice of medication.
After the consultation the doctor explains to the researcher that she thinks it is 
problematic, when patients think they have expert knowledge, because managing 
arthritis is a very complex and demanding field even for doctors who specialize 
in it. The doctor sees Bettina’s unwillingness to change medication as an irratio-
nal fear of the side-effects of cytotoxic drugs, which many patients know are also 
used in cancer treatment (i.e. chemotherapy4), although in much higher doses. The 
doctor sums up: 
“So with her I have a really hard time providing informed treatment. It is much 
easier with the kind of patients to whom I can explain what I can and what I cannot 
do. And also, when my colleagues ask why she is given Salazopyrin… I will have to 
write in the journal that it was HER choice and that she does not want the Methro-
trexate treatment even though we all know she ought to have it … She is typical for 
the patients who are difficult to get involved because she is so prejudiced.”
The example illustrates that this particular patient is considered ‘trespassing’ 
when she states her treatment preferences with reference to clinical knowledge. 
It also illustrates the lack of agreement about what patient participation and dia-
logue is in practice. While the doctor agrees that patient participation is legitimate 
to this type of consultation, she seems to be expecting a kind of participation 
which is similar to a more traditional paternalistic approach to clinical decision-
making. She expects that when she puts forward her opinion on the right choice 
of medication, the patient will accept this as the right choice. Similar findings are 
described by Stone (1997) in a study of diabetes care, where clinicians perceived 
patients’ way of participating as illegitimate challenges to their professional ex-
pertise, which obstructed proper clinical practice.
In this case, the doctor’s comments emphasize her superior claim to the clinical 
knowledge domain. 
Discussion
This article presents three cases about patients, who were involved in negotiati-
ons over legitimate use of different types of knowledge: Peter withheld informa-
tion about his medication to avoid making what he saw as illegitimate claims to 
the doctor’s knowledge domain. Jane experienced how her skills and knowledge 
about the management of her diabetes were overruled by work routines in the 
surgical ward. And Bettina’s doctor perceived her attempt to engage in decision-
making about her medication as a communication breakdown, which prevented 
her from getting the best possible treatment, seen from a clinical perspective.
The patients all describe themselves as active and responsible patients, as did 
the majority of participants in the three studies. People construct personal narrati-
ves in accordance with the cultural norms and ideals they are surrounded by (see 
for instance Taylor 1989). It is therefore not surprising that patients with chronic 
illnesses construct their narratives of self and health in accordance with domi-
nant ideals of responsibility, active engagement and participation, and recognize 
the necessity of taking responsibility both at home and in the clinical encounter. 
However, acting the responsible, participating patient appears to be difficult in 
some clinical situations. The cases presented in this paper illustrate that patients 
navigate between expectations of being active and responsible patients, and the 
more passive patient role which they are offered in certain clinical situations. This 
paradox requires a constant negotiation of strategies, which becomes most visible 
when the patients attempt to interfere with the professional domain of pharma-
cological treatment. Choosing how to treat a given disease with medication is ar-
guably among the most important and challenging areas of clinical decision-ma-
king. Yet, several studies have found that, despite interest in the principles of sha-
red decision making on policy making level, patients rarely participate actively in 
decisions about their treatment (Makoul, Arntson, & Schofield 1995; Stevenson, 
Barry, Britten, Barber, & Bradley 2000; The Health Foundation 2012; Coulter & Col-
lins 2011). Partly, this could be due to structural barriers – lack of time, changing 
doctors, standardization of care etc. However,  patients may also refrain from par-
ticipating in decision making because they are cautious about challenging clinical 
authority. In their book about the social life of medicines, Whyte et al. (2002) argue 
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that drugs are the essence of medical practice, and therefore a symbolic extension 
of the doctor (Whyte, Van der Geest, & Hardon 2002). Thus, in writing a prescrip-
tion the doctor exercises his professional authority and distances himself form the 
lay person. This gives the doctor a very specific power in the clinical encounter 
with the patient. When patients wish to have a say in the choice of medicine, like 
Bettina did, they not only venture into a domain that traditionally belongs exclu-
sively to the doctor. This can be interpreted as an implicit challenge to the doctor’s 
professional authority in the clinical encounter. Ainsworth-Vaughn (1998) points 
out that a patient’s deference does not necessarily imply passivity or a lack of active 
engagement in the treatment process (Ainsworth-Vaughn 1998). When being ad-
mitted to hospital wards, people find themselves in an unfamiliar place with their 
health at stake. They are therefore likely to be very cautious of indications about 
expected behaviour in different situations. If patients assume that health profes-
sionals who approve of their behaviour are more likely to treat them well, they 
will find themselves in a double bind of opposite risks: On the one hand, disag-
reeing about knowledge could anger health professionals and hypothetically lead 
to sub-optimal care. And on the other hand, withholding information about their 
medication and symptoms could lead to complications in their treatment. When 
Peter, Jane and Bettina weigh up the benefits and risks of sharing their knowledge 
of medication in a clinical encounter, they do so because they are well aware that 
when it comes to the prescription of medication, they enter a domain, which is at 
the heart of physician competence and authority. The cases thus show that it can 
be difficult for patients to participate in decision making about pharmacological 
treatment if they make use of clinical knowledge, and if their participation is not 
explicitly invited and welcomed by health professionals. 
Concluding remarks 
This article raises questions about how principles of patient participation can be 
implemented in practice: Who has legitimate right to use which kinds of know-
ledge? Who is competent to make which kind of judgments? How can patients 
and health professionals solve disagreements about treatment to the satisfaction 
of both parties? 
These questions are not least important for the current interest in implementing 
the principles of shared decision making in clinical practice across health care 
systems. In the discourse of shared decision making, patient knowledge is un-
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derstood as the extensive knowledge about his/her own everyday life and illness. 
However, it may be relevant for patients with chronic disease to refer not only to 
this type of knowledge, but also to the knowledge about medication they may 
have acquired through long term management of their condition(s). Our studies 
show that the ideal of open dialogue, equality and partnership between patients 
and health professionals nevertheless award limited space for patients’ know-
ledge about medication. Unfortunately, withheld or incorrect knowledge about 
medication can lead to treatment delays and unnecessary suffering for patients, 
resulting in wasted resources. One way to overcome this issue is to invite patients 
to bring their clinical knowledge forward in the same way they are invited to 
bring forward their knowledge of living with their disease, their perceptions of 
risk, their treatment preferences etc.  
If patients’ clinical knowledge is to have a place in the doctor-patient commu-
nication, doctors will have to actively invite them to disclose this knowledge. As 
our cases show, patients may be very reluctant to venture into clinical territory. 
One step towards this goal could be a widening of the notion of shared decision 
making to extend the concept of partnership to encompass the extensive clinical 
knowledge that some patients with chronic disease acquire over time. Seeing the 
doctor and patient as partners does not mean that their roles are interchangeable 
or their knowledge the same. In its ideal sense, the concept of partnership implies 
a respectful dialogue that includes the knowledge and perspectives of both pa-
tient and health professional. Seen this way, the question of ‘who knows best’ may 
be less relevant. Instead we should start asking ‘how can doctors – expertise and 
authority intact – make space for the full breadth of patient knowledge? With the 
ultimate goal of better treatment.  
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Notes
1: Another aspect of patient participation concerns the evaluation and improvement of 
health care delivery through the monitoring of patient satisfaction with the services 
they encounter (Coulter & Ellins 2006)
2: Strauss terms all the actions of patients in relation to treatment as ‘work’ and considers 
this comparable to the work of health professionals.
3: ‘Hypo’ is short for hypoglycaemic episode.
4: Methotraxate is used in high doses in cancer treatment, but also in low doses when 
treating for instance arthritis. It is usually well tolerated in low doses, while adverse 
drug reactions (incl., nausea, vomiting, diarrhea and fatigue) are more common in high 
doses.
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